Case number 2016-2722
Sanofi v. Watson Laboratories Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | SANOFI v. WATSON LABORATORIES INC. [OPINION] [precedential] (0) |
| Dec 18, 2017 | 50 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by Clerk of Court. [483394] [16-2722, 16-2726] [JAB] [Entered: 12/18/2017 03:42 PM] (1) |
| Nov 9, 2017 | 49 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (Precedential Opinion). (For the Court: Prost,Chief Judge; Wallach,Circuit Judge and Taranto,Circuit Judge). [474190] [16-2722, 16-2726] [SJ] [Entered: 11/09/2017 09:30 AM] (29) |
| Sep 7, 2017 | 48 | Submitted after ORAL ARGUMENT by Maureen L. Rurka for Sandoz Inc. and Watson Laboratories Inc. and William E. Solander for Sanofi-Aventis U.S., LLC and Sanofi. Panel: Judge: Prost , Judge: Wallach , Judge: Taranto. [459247] [JAB] [Entered: 09/07/2017 10:29 AM] (0) |
| Aug 15, 2017 | 47 | Response to oral argument order from the Appellees Sanofi and Sanofi-Aventis U.S., LLC. designating William E. Solander as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [454156] [Zachary Garrett] [Entered: 08/15/2017 03:39 PM] (0) |
| Aug 11, 2017 | 46 | Response to oral argument order from the Appellants Sandoz Inc. and Watson Laboratories Inc.. designating Maureen L. Rurka as arguing attorney. Designated time for argument: 11 minutes. Designated time for rebuttal: 4 minutes. Service of other counsel by Notice of Docket Activity from this entry. [453282] [Tyler Johannes] [Entered: 08/11/2017 11:08 AM] (0) |
| Jul 21, 2017 | 45 | NOTICE OF CALENDARING. Panel: 1709G. Case scheduled Sep 07, 2017 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 201. Response to oral argument order due: 08/15/2017. Arguing counsel is required to check-in with the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [448312] [JAB] [Entered: 07/21/2017 12:57 PM] (0) |
| Apr 5, 2017 | 44 | Notice from Appellees Sanofi and Sanofi-Aventis U.S., LLC regarding conflicts with oral argument (June 5-9, 2017; July 14, 2017; September 8, 2017). Service: 04/05/2017 by email. [421844] [Zachary Garrett] [Entered: 04/05/2017 05:19 PM] (4) |
| Apr 5, 2017 | 43 | Notice from Appellant Watson Laboratories Inc. regarding conflicts with oral argument (April 6, 7 or 10, 2017, May 1-5 or 8, 2017, July 10-14, 2017 and August 7-11, 2017). Service: 04/05/2017 by email. [421626] [Natalie Clayton] [Entered: 04/05/2017 11:20 AM] (4) |
| Mar 31, 2017 | 42 | 6 paper copies of the Joint Appendix [40] received from Appellants Sandoz Inc. and Watson Laboratories Inc. [421045] [KW] [Entered: 04/03/2017 03:45 PM] (0) |
| Mar 29, 2017 | 41 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 04/05/2017. [419965] [JB] [Entered: 03/29/2017 02:06 PM] (0) |
| Mar 28, 2017 | 40 | APPENDIX FILED for Sandoz Inc. and Watson Laboratories Inc. [38]. Number of Pages: 717. Service: 03/28/2017 by email. The paper copies of the brief should be received by the court on or before 04/05/2017. [419963] [JB] [Entered: 03/29/2017 02:05 PM] (717) |
| Mar 28, 2017 | 39 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Sanofi and Sanofi-Aventis U.S., LLC. Service: 03/28/2017 by email. [419711] [Zachary Garrett] [Entered: 03/28/2017 07:18 PM] (4) |
| Mar 28, 2017 | 38 | TENDERED from Appellants Sandoz Inc., Watson Laboratories Inc. and Appellees Sanofi and Sanofi-Aventis U.S., LLC. Title: JOINT APPENDIX. Service: 03/28/2017 by email. [419620] [Christopher McArdle] [Entered: 03/28/2017 02:55 PM] (717) |
| Mar 28, 2017 | 37 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Sandoz Inc.. Service: 03/28/2017 by email. [419540] [Maureen Rurka] [Entered: 03/28/2017 01:39 PM] (4) |
| Mar 28, 2017 | 36 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Watson Laboratories Inc.. Service: 03/28/2017 by email. [419515] [Natalie Clayton] [Entered: 03/28/2017 12:43 PM] (4) |
| Mar 28, 2017 | 35 | Statement of Compliance with Fed. Cir. R. 33 for Appellants Sandoz Inc., Watson Laboratories Inc. and Appellees Sanofi and Sanofi-Aventis U.S., LLC. Service: 03/28/2017 by email. [419513] [Natalie Clayton] [Entered: 03/28/2017 12:40 PM] (3) |
| Mar 23, 2017 | 34 | 6 paper copies of the Reply Brief [33] received from Appellants Sandoz Inc. and Watson Laboratories Inc. [418386] [KW] [Entered: 03/23/2017 02:05 PM] (0) |
| Mar 21, 2017 | 33 | REPLY BRIEF FILED for Appellants Sandoz Inc. and Watson Laboratories Inc. [32]. Number of Pages: 32. Service: 03/21/2017 by email. The paper copies of the brief should be received by the court on or before 03/29/2017. Appendix is due 03/28/2017. [417739] [JB] [Entered: 03/22/2017 09:20 AM] (41) |
| Mar 21, 2017 | 32 | TENDERED from Appellants Sandoz Inc. and Watson Laboratories Inc.. Title: REPLY BRIEF. Service: 03/21/2017 by email. [417615] [Christopher McArdle] [Entered: 03/21/2017 04:14 PM] (41) |
| Mar 10, 2017 | 31 | 6 paper copies of the Response Brief [30] received from Appellees Sanofi and Sanofi-Aventis U.S., LLC. [414460] [KW] [Entered: 03/10/2017 02:19 PM] (0) |
| Mar 7, 2017 | 30 | BRIEF FILED for Appellees Sanofi and Sanofi-Aventis U.S., LLC [29]. Number of Pages: 69. Service: 03/07/2017 by email. The paper copies of the brief should be received by the court on or before 03/15/2017. Appellants Sandoz Inc. and Watson Laboratories Inc. reply brief is due 03/21/2017. [413531] [JB] [Entered: 03/08/2017 03:41 PM] (81) |
| Mar 7, 2017 | 29 | TENDERED from Appellees Sanofi and Sanofi-Aventis U.S., LLC. Title: RESPONSE BRIEF. Service: 03/07/2017 by email. [413193] [William Solander] [Entered: 03/07/2017 05:38 PM] (81) |
| Mar 7, 2017 | 28 | Entry of appearance for Anna Dwyer as of counsel for Appellees Sanofi and Sanofi-Aventis U.S., LLC. Service: 03/07/2017 by email. [412980] [Anna Dwyer] [Entered: 03/07/2017 11:21 AM] (2) |
| Mar 7, 2017 | 27 | Entry of appearance for James Tyminski as of counsel for Appellees Sanofi and Sanofi-Aventis U.S., LLC. Service: 03/07/2017 by email. [412978] [James Tyminski] [Entered: 03/07/2017 11:15 AM] (2) |
| Feb 13, 2017 | 26 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: motion to extend time to file appellee/respondent/cross-appellant principal brief Docket No. [24], ERROR: The motion does not use the official case caption. CORRECTION: : Future filings should use the official case caption as listed on the docket sheet. There is no need to refile the motion as it has been granted. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [406986] [JB] [Entered: 02/13/2017 04:02 PM] (0) |
| Feb 13, 2017 | 25 | **TEXT ONLY** ORDER granting motion to extend time to file appellee/respondent/cross-appellant principal brief [24] filed by Appellees Sanofi-Aventis U.S., LLC and Sanofi. Appellees Sanofi and Sanofi-Aventis U.S., LLC brief is due 03/07/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [406982] [JB] [Entered: 02/13/2017 03:59 PM] (0) |
| Feb 13, 2017 | 24 | MOTION of Appellees Sanofi and Sanofi-Aventis U.S., LLC to extend the time to 03/07/2017 at 11:59 pm to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 02/13/2017 by email. [406947] [Zachary Garrett] [Entered: 02/13/2017 03:19 PM] (5) |
| Jan 17, 2017 | 23 | 6 paper copies of the Opening Brief [22] received from Appellants Sandoz Inc. and Watson Laboratories Inc. [399599] [KW] [Entered: 01/17/2017 03:13 PM] (0) |
| Jan 12, 2017 | 22 | BRIEF FILED for Appellants Sandoz Inc. and Watson Laboratories Inc. [21]. Number of Pages: 66. Service: 01/12/2017 by email. The paper copies of the brief should be received by the court on or before 01/24/2017. Appellees Sanofi and Sanofi-Aventis U.S., LLC brief is due 02/21/2017. [398975] [JB] [Entered: 01/13/2017 09:57 AM] (185) |
| Jan 12, 2017 | 21 | TENDERED from Appellants Sandoz Inc. and Watson Laboratories Inc.. Title: OPENING BRIEF. Service: 01/12/2017 by email. [398411] [Christopher McArdle] [Entered: 01/12/2017 04:34 PM] (185) |
| Jan 11, 2017 | 20 | Entry of appearance for Tyler G. Johannes as of counsel for Appellant Sandoz Inc.. Service: 01/11/2017 by email. [398039] [Tyler Johannes] [Entered: 01/11/2017 05:14 PM] (1) |
| Nov 21, 2016 | 19 | **TEXT ONLY** ORDER granting motion to extend time to file appellant/petitioner principal brief [18] filed by Appellants Watson Laboratories Inc and Sandoz Inc. Brief due 01/12/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [385113] [JB] [Entered: 11/21/2016 03:18 PM] (0) |
| Nov 21, 2016 | 18 | MOTION of Appellant Watson Laboratories Inc. to extend the time to 01/12/2017 at 11:59 pm to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 11/21/2016 by email. [384968] [Natalie Clayton] [Entered: 11/21/2016 12:13 PM] (11) |
| Nov 9, 2016 | 17 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a)and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [381620] [JB] [Entered: 11/09/2016 12:14 PM] (0) |
| Oct 13, 2016 | 16 | Docketing Statement for the Appellees Sanofi and Sanofi-Aventis U.S., LLC. Service: 10/13/2016 by email. [373980] [Zachary Garrett] [Entered: 10/13/2016 04:14 PM] (4) |
| Oct 13, 2016 | 15 | Certificate of Interest for the Appellees Sanofi and Sanofi-Aventis U.S., LLC. Service: 10/13/2016 by email. [373977] [Zachary Garrett] [Entered: 10/13/2016 04:09 PM] (2) |
| Oct 13, 2016 | 14 | Entry of appearance for William E. Solander as principal counsel for Appellees Sanofi and Sanofi-Aventis U.S., LLC. Service: 10/13/2016 by email. [373971] [Zachary Garrett] [Entered: 10/13/2016 03:58 PM] (2) |
| Oct 13, 2016 | 13 | Entry of appearance for Daniel J. Minion as of counsel for Appellees Sanofi and Sanofi-Aventis U.S., LLC. Service: 10/13/2016 by email. [373968] [Zachary Garrett] [Entered: 10/13/2016 03:54 PM] (2) |
| Oct 13, 2016 | 12 | Entry of appearance for Zachary L. Garrett as of counsel for Appellees Sanofi and Sanofi-Aventis U.S., LLC. Service: 10/13/2016 by email. [373966] [Zachary Garrett] [Entered: 10/13/2016 03:50 PM] (2) |
| Oct 13, 2016 | 11 | Docketing Statement for the Appellant Sandoz Inc.. Service: 10/13/2016 by email. [373814] [Maureen Rurka] [Entered: 10/13/2016 11:19 AM] (4) |
| Oct 13, 2016 | 10 | Certificate of Interest for the Appellant Sandoz Inc.. Service: 10/13/2016 by email. [373812] [Maureen Rurka] [Entered: 10/13/2016 11:18 AM] (2) |
| Oct 13, 2016 | 9 | Entry of appearance for Julia Mano Johnson as of counsel for Appellant Sandoz Inc.. Service: 10/13/2016 by email. [373806] [Julia Johnson] [Entered: 10/13/2016 11:15 AM] (2) |
| Oct 13, 2016 | 8 | Entry of appearance for Maureen L. Rurka as principal counsel for Appellant Sandoz Inc.. Service: 10/13/2016 by email. [373800] [Maureen Rurka] [Entered: 10/13/2016 11:11 AM] (2) |
| Oct 13, 2016 | 7 | Docketing Statement for the Appellant Watson Laboratories Inc.. Service: 10/13/2016 by email. [373797] [Natalie Clayton] [Entered: 10/13/2016 11:05 AM] (3) |
| Oct 13, 2016 | 6 | Certificate of Interest for the Appellant Watson Laboratories Inc.. Service: 10/13/2016 by email. [373792] [Natalie Clayton] [Entered: 10/13/2016 11:04 AM] (1) |
| Oct 13, 2016 | 5 | Entry of appearance for Yi Wen Wu as of counsel for Appellant Watson Laboratories Inc.. Service: 10/13/2016 by email. [373788] [Yi Wen Wu] [Entered: 10/13/2016 11:01 AM] (1) |
| Oct 13, 2016 | 4 | Entry of appearance for Christopher L. McArdle as of counsel for Appellant Watson Laboratories Inc.. Service: 10/13/2016 by email. [373785] [Christopher McArdle] [Entered: 10/13/2016 10:57 AM] (1) |
| Oct 13, 2016 | 3 | Entry of appearance for Natalie C. Clayton as principal counsel for Appellant Watson Laboratories Inc.. Service: 10/13/2016 by email. [373782] [Natalie Clayton] [Entered: 10/13/2016 10:53 AM] (1) |
| Sep 29, 2016 | 2 | Note to file: The following cases are associated:16-2722 Lead with 16-2726 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [370081] [JB] [Entered: 09/29/2016 10:17 AM] (0) |
| Sep 29, 2016 | 1 | Appeal docketed. Received: 09/27/2016. [370066]Entry of Appearance due 10/13/2016. Certificate of Interest is due on 10/13/2016. Docketing Statement due 10/13/2016. Appellant/Petitioner's brief is due 11/28/2016. [JB] [Entered: 09/29/2016 09:47 AM] (44) |
